カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界の犬用インフルエンザワクチン市場2022年：液体、粉体

◆英語タイトル：Global Canine Influenza Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書（GIR22MY8761）◆商品コード：GIR22MY8761
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2022年5月（※2025年版があります。お問い合わせください。）
◆ページ数：76
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

犬用インフルエンザワクチン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の犬用インフルエンザワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

犬用インフルエンザワクチン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・液体、粉体

用途別セグメントは次のように区分されます。
・家庭用、 ペットクリニック、 その他

世界の犬用インフルエンザワクチン市場の主要な市場プレーヤーは以下のとおりです。
・Merck Animal Health、Zoetis、CSL Limited

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、犬用インフルエンザワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な犬用インフルエンザワクチンメーカーの企業概要、2019年～2022年までの犬用インフルエンザワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な犬用インフルエンザワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別犬用インフルエンザワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの犬用インフルエンザワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での犬用インフルエンザワクチン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および犬用インフルエンザワクチンの産業チェーンを掲載しています。
・第13、14、15章では、犬用インフルエンザワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Merck Animal Health、Zoetis、CSL Limited
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：液体、粉体
・用途別分析2017年-2028年：家庭用、 ペットクリニック、 その他
・犬用インフルエンザワクチンの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・犬用インフルエンザワクチンのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・犬用インフルエンザワクチンのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・犬用インフルエンザワクチンの南米市場規模2017年-2028年：ブラジル、アルゼンチン
・犬用インフルエンザワクチンの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Canine Influenza Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Canine Influenza Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Home accounting for % of the Canine Influenza Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Liquid segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Canine Influenza Vaccine include Merck Animal Health, Zoetis, CSL Limited, , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Canine Influenza Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Liquid
Powder
Market segment by Application can be divided into
Home
Pet Clinic
Others
The key market players for global Canine Influenza Vaccine market are listed below:
Merck Animal Health
Zoetis
CSL Limited
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Canine Influenza Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Canine Influenza Vaccine, with price, sales, revenue and global market share of Canine Influenza Vaccine from 2019 to 2022.
Chapter 3, the Canine Influenza Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Canine Influenza Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Canine Influenza Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Canine Influenza Vaccine.
Chapter 13, 14, and 15, to describe Canine Influenza Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Canine Influenza Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Canine Influenza Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Liquid
1.2.3 Powder
1.3 Market Analysis by Application
1.3.1 Overview: Global Canine Influenza Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Home
1.3.3 Pet Clinic
1.3.4 Others
1.4 Global Canine Influenza Vaccine Market Size & Forecast
1.4.1 Global Canine Influenza Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Canine Influenza Vaccine Sales in Volume (2017-2028)
1.4.3 Global Canine Influenza Vaccine Price (2017-2028)
1.5 Global Canine Influenza Vaccine Production Capacity Analysis
1.5.1 Global Canine Influenza Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Canine Influenza Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Canine Influenza Vaccine Market Drivers
1.6.2 Canine Influenza Vaccine Market Restraints
1.6.3 Canine Influenza Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Merck Animal Health
2.1.1 Merck Animal Health Details
2.1.2 Merck Animal Health Major Business
2.1.3 Merck Animal Health Canine Influenza Vaccine Product and Services
2.1.4 Merck Animal Health Canine Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Zoetis
2.2.1 Zoetis Details
2.2.2 Zoetis Major Business
2.2.3 Zoetis Canine Influenza Vaccine Product and Services
2.2.4 Zoetis Canine Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 CSL Limited
2.3.1 CSL Limited Details
2.3.2 CSL Limited Major Business
2.3.3 CSL Limited Canine Influenza Vaccine Product and Services
2.3.4 CSL Limited Canine Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Canine Influenza Vaccine Breakdown Data by Manufacturer
3.1 Global Canine Influenza Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Canine Influenza Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Canine Influenza Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Canine Influenza Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Canine Influenza Vaccine Manufacturer Market Share in 2021
3.5 Global Canine Influenza Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Canine Influenza Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Canine Influenza Vaccine Market Size by Region
4.1.1 Global Canine Influenza Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Canine Influenza Vaccine Revenue by Region (2017-2028)
4.2 North America Canine Influenza Vaccine Revenue (2017-2028)
4.3 Europe Canine Influenza Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Canine Influenza Vaccine Revenue (2017-2028)
4.5 South America Canine Influenza Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Canine Influenza Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Canine Influenza Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Canine Influenza Vaccine Revenue by Type (2017-2028)
5.3 Global Canine Influenza Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Canine Influenza Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Canine Influenza Vaccine Revenue by Application (2017-2028)
6.3 Global Canine Influenza Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Canine Influenza Vaccine Sales by Type (2017-2028)
7.2 North America Canine Influenza Vaccine Sales by Application (2017-2028)
7.3 North America Canine Influenza Vaccine Market Size by Country
7.3.1 North America Canine Influenza Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Canine Influenza Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Canine Influenza Vaccine Sales by Type (2017-2028)
8.2 Europe Canine Influenza Vaccine Sales by Application (2017-2028)
8.3 Europe Canine Influenza Vaccine Market Size by Country
8.3.1 Europe Canine Influenza Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Canine Influenza Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Canine Influenza Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Canine Influenza Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Canine Influenza Vaccine Market Size by Region
9.3.1 Asia-Pacific Canine Influenza Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Canine Influenza Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Canine Influenza Vaccine Sales by Type (2017-2028)
10.2 South America Canine Influenza Vaccine Sales by Application (2017-2028)
10.3 South America Canine Influenza Vaccine Market Size by Country
10.3.1 South America Canine Influenza Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Canine Influenza Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Canine Influenza Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Canine Influenza Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Canine Influenza Vaccine Market Size by Country
11.3.1 Middle East & Africa Canine Influenza Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Canine Influenza Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Canine Influenza Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Canine Influenza Vaccine
12.3 Canine Influenza Vaccine Production Process
12.4 Canine Influenza Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Canine Influenza Vaccine Typical Distributors
13.3 Canine Influenza Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Canine Influenza Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Canine Influenza Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 4. Merck Animal Health Major Business
Table 5. Merck Animal Health Canine Influenza Vaccine Product and Services
Table 6. Merck Animal Health Canine Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Zoetis Basic Information, Manufacturing Base and Competitors
Table 8. Zoetis Major Business
Table 9. Zoetis Canine Influenza Vaccine Product and Services
Table 10. Zoetis Canine Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 12. CSL Limited Major Business
Table 13. CSL Limited Canine Influenza Vaccine Product and Services
Table 14. CSL Limited Canine Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Global Canine Influenza Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Doses)
Table 16. Global Canine Influenza Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 17. Market Position of Manufacturers in Canine Influenza Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 18. Global Canine Influenza Vaccine Production Capacity by Company, (K Doses): 2020 VS 2021
Table 19. Head Office and Canine Influenza Vaccine Production Site of Key Manufacturer
Table 20. Canine Influenza Vaccine New Entrant and Capacity Expansion Plans
Table 21. Canine Influenza Vaccine Mergers & Acquisitions in the Past Five Years
Table 22. Global Canine Influenza Vaccine Sales by Region (2017-2022) & (K Doses)
Table 23. Global Canine Influenza Vaccine Sales by Region (2023-2028) & (K Doses)
Table 24. Global Canine Influenza Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 25. Global Canine Influenza Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 26. Global Canine Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
Table 27. Global Canine Influenza Vaccine Sales by Type (2023-2028) & (K Doses)
Table 28. Global Canine Influenza Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 29. Global Canine Influenza Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 30. Global Canine Influenza Vaccine Price by Type (2017-2022) & (USD/Dose)
Table 31. Global Canine Influenza Vaccine Price by Type (2023-2028) & (USD/Dose)
Table 32. Global Canine Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
Table 33. Global Canine Influenza Vaccine Sales by Application (2023-2028) & (K Doses)
Table 34. Global Canine Influenza Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 35. Global Canine Influenza Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 36. Global Canine Influenza Vaccine Price by Application (2017-2022) & (USD/Dose)
Table 37. Global Canine Influenza Vaccine Price by Application (2023-2028) & (USD/Dose)
Table 38. North America Canine Influenza Vaccine Sales by Country (2017-2022) & (K Doses)
Table 39. North America Canine Influenza Vaccine Sales by Country (2023-2028) & (K Doses)
Table 40. North America Canine Influenza Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 41. North America Canine Influenza Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 42. North America Canine Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
Table 43. North America Canine Influenza Vaccine Sales by Type (2023-2028) & (K Doses)
Table 44. North America Canine Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
Table 45. North America Canine Influenza Vaccine Sales by Application (2023-2028) & (K Doses)
Table 46. Europe Canine Influenza Vaccine Sales by Country (2017-2022) & (K Doses)
Table 47. Europe Canine Influenza Vaccine Sales by Country (2023-2028) & (K Doses)
Table 48. Europe Canine Influenza Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 49. Europe Canine Influenza Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 50. Europe Canine Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
Table 51. Europe Canine Influenza Vaccine Sales by Type (2023-2028) & (K Doses)
Table 52. Europe Canine Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
Table 53. Europe Canine Influenza Vaccine Sales by Application (2023-2028) & (K Doses)
Table 54. Asia-Pacific Canine Influenza Vaccine Sales by Region (2017-2022) & (K Doses)
Table 55. Asia-Pacific Canine Influenza Vaccine Sales by Region (2023-2028) & (K Doses)
Table 56. Asia-Pacific Canine Influenza Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 57. Asia-Pacific Canine Influenza Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 58. Asia-Pacific Canine Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
Table 59. Asia-Pacific Canine Influenza Vaccine Sales by Type (2023-2028) & (K Doses)
Table 60. Asia-Pacific Canine Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
Table 61. Asia-Pacific Canine Influenza Vaccine Sales by Application (2023-2028) & (K Doses)
Table 62. South America Canine Influenza Vaccine Sales by Country (2017-2022) & (K Doses)
Table 63. South America Canine Influenza Vaccine Sales by Country (2023-2028) & (K Doses)
Table 64. South America Canine Influenza Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 65. South America Canine Influenza Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 66. South America Canine Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
Table 67. South America Canine Influenza Vaccine Sales by Type (2023-2028) & (K Doses)
Table 68. South America Canine Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
Table 69. South America Canine Influenza Vaccine Sales by Application (2023-2028) & (K Doses)
Table 70. Middle East & Africa Canine Influenza Vaccine Sales by Region (2017-2022) & (K Doses)
Table 71. Middle East & Africa Canine Influenza Vaccine Sales by Region (2023-2028) & (K Doses)
Table 72. Middle East & Africa Canine Influenza Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 73. Middle East & Africa Canine Influenza Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 74. Middle East & Africa Canine Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
Table 75. Middle East & Africa Canine Influenza Vaccine Sales by Type (2023-2028) & (K Doses)
Table 76. Middle East & Africa Canine Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
Table 77. Middle East & Africa Canine Influenza Vaccine Sales by Application (2023-2028) & (K Doses)
Table 78. Canine Influenza Vaccine Raw Material
Table 79. Key Manufacturers of Canine Influenza Vaccine Raw Materials
Table 80. Direct Channel Pros & Cons
Table 81. Indirect Channel Pros & Cons
Table 82. Canine Influenza Vaccine Typical Distributors
Table 83. Canine Influenza Vaccine Typical Customers
List of Figures
Figure 1. Canine Influenza Vaccine Picture
Figure 2. Global Canine Influenza Vaccine Revenue Market Share by Type in 2021
Figure 3. Liquid
Figure 4. Powder
Figure 5. Global Canine Influenza Vaccine Revenue Market Share by Application in 2021
Figure 6. Home
Figure 7. Pet Clinic
Figure 8. Others
Figure 9. Global Canine Influenza Vaccine Revenue, (USD Million) & (K Doses): 2017 & 2021 & 2028
Figure 10. Global Canine Influenza Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Canine Influenza Vaccine Sales (2017-2028) & (K Doses)
Figure 12. Global Canine Influenza Vaccine Price (2017-2028) & (USD/Dose)
Figure 13. Global Canine Influenza Vaccine Production Capacity (2017-2028) & (K Doses)
Figure 14. Global Canine Influenza Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Canine Influenza Vaccine Market Drivers
Figure 16. Canine Influenza Vaccine Market Restraints
Figure 17. Canine Influenza Vaccine Market Trends
Figure 18. Global Canine Influenza Vaccine Sales Market Share by Manufacturer in 2021
Figure 19. Global Canine Influenza Vaccine Revenue Market Share by Manufacturer in 2021
Figure 20. Canine Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Canine Influenza Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Canine Influenza Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Canine Influenza Vaccine Sales Market Share by Region (2017-2028)
Figure 24. Global Canine Influenza Vaccine Revenue Market Share by Region (2017-2028)
Figure 25. North America Canine Influenza Vaccine Revenue (2017-2028) & (USD Million)
Figure 26. Europe Canine Influenza Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Canine Influenza Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. South America Canine Influenza Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Canine Influenza Vaccine Revenue (2017-2028) & (USD Million)
Figure 30. Global Canine Influenza Vaccine Sales Market Share by Type (2017-2028)
Figure 31. Global Canine Influenza Vaccine Revenue Market Share by Type (2017-2028)
Figure 32. Global Canine Influenza Vaccine Price by Type (2017-2028) & (USD/Dose)
Figure 33. Global Canine Influenza Vaccine Sales Market Share by Application (2017-2028)
Figure 34. Global Canine Influenza Vaccine Revenue Market Share by Application (2017-2028)
Figure 35. Global Canine Influenza Vaccine Price by Application (2017-2028) & (USD/Dose)
Figure 36. North America Canine Influenza Vaccine Sales Market Share by Type (2017-2028)
Figure 37. North America Canine Influenza Vaccine Sales Market Share by Application (2017-2028)
Figure 38. North America Canine Influenza Vaccine Sales Market Share by Country (2017-2028)
Figure 39. North America Canine Influenza Vaccine Revenue Market Share by Country (2017-2028)
Figure 40. United States Canine Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Canine Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Canine Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Canine Influenza Vaccine Sales Market Share by Type (2017-2028)
Figure 44. Europe Canine Influenza Vaccine Sales Market Share by Application (2017-2028)
Figure 45. Europe Canine Influenza Vaccine Sales Market Share by Country (2017-2028)
Figure 46. Europe Canine Influenza Vaccine Revenue Market Share by Country (2017-2028)
Figure 47. Germany Canine Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Canine Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Canine Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Canine Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Canine Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Canine Influenza Vaccine Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Canine Influenza Vaccine Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Canine Influenza Vaccine Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Canine Influenza Vaccine Revenue Market Share by Region (2017-2028)
Figure 56. China Canine Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Canine Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Canine Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Canine Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Canine Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Canine Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Canine Influenza Vaccine Sales Market Share by Type (2017-2028)
Figure 63. South America Canine Influenza Vaccine Sales Market Share by Application (2017-2028)
Figure 64. South America Canine Influenza Vaccine Sales Market Share by Country (2017-2028)
Figure 65. South America Canine Influenza Vaccine Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Canine Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Canine Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Canine Influenza Vaccine Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Canine Influenza Vaccine Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Canine Influenza Vaccine Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Canine Influenza Vaccine Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Canine Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Canine Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Canine Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Canine Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Canine Influenza Vaccine in 2021
Figure 77. Manufacturing Process Analysis of Canine Influenza Vaccine
Figure 78. Canine Influenza Vaccine Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の犬用インフルエンザワクチン市場2022年：液体、粉体(Global Canine Influenza Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 再集合体鳥インフルエンザウイルスワクチンのグローバル市場予測2023-2029
  • 世界のインフルエンザワクチン注射市場インサイト及び予測（三価インフルエンザワクチン、四価インフルエンザワクチン）
  • 世界のインフルエンザ用ワクチン市場2022年：三価インフルエンザ用ワクチン、四価インフルエンザ用ワクチン
  • 世界の馬インフルエンザワクチン市場2022年：液体、粉末
  • 世界のインフルエンザNA阻害剤市場2022年：ザナミビル、オセルタミビル、ペラミビル